BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

764 related articles for article (PubMed ID: 30647431)

  • 21. Personalised organs-on-chips: functional testing for precision medicine.
    van den Berg A; Mummery CL; Passier R; van der Meer AD
    Lab Chip; 2019 Jan; 19(2):198-205. PubMed ID: 30506070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold.
    Hu LF; Yang X; Lan HR; Fang XL; Chen XY; Jin KT
    Exp Cell Res; 2021 Nov; 408(2):112858. PubMed ID: 34600901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On-chip anticancer drug screening - Recent progress in microfluidic platforms to address challenges in chemotherapy.
    Dhiman N; Kingshott P; Sumer H; Sharma CS; Rath SN
    Biosens Bioelectron; 2019 Jul; 137():236-254. PubMed ID: 31121461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microfluidic 3D models of cancer.
    Sung KE; Beebe DJ
    Adv Drug Deliv Rev; 2014 Dec; 79-80():68-78. PubMed ID: 25017040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Organ-on-a-Chip for Cancer and Immune Organs Modeling.
    Sun W; Luo Z; Lee J; Kim HJ; Lee K; Tebon P; Feng Y; Dokmeci MR; Sengupta S; Khademhosseini A
    Adv Healthc Mater; 2019 Feb; 8(4):e1801363. PubMed ID: 30605261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tomorrow today: organ-on-a-chip advances towards clinically relevant pharmaceutical and medical in vitro models.
    Rothbauer M; Rosser JM; Zirath H; Ertl P
    Curr Opin Biotechnol; 2019 Feb; 55():81-86. PubMed ID: 30189349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erratum: Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips.
    J Vis Exp; 2019 May; (147):. PubMed ID: 31067212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Organs-on-Chips Platforms Are Everywhere: A Zoom on Biomedical Investigation.
    Zommiti M; Connil N; Tahrioui A; Groboillot A; Barbey C; Konto-Ghiorghi Y; Lesouhaitier O; Chevalier S; Feuilloley MGJ
    Bioengineering (Basel); 2022 Nov; 9(11):. PubMed ID: 36354557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organoids: approaches and utility in cancer research.
    Zhou B; Feng Z; Xu J; Xie J
    Chin Med J (Engl); 2023 Aug; 136(15):1783-1793. PubMed ID: 37365679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Organ-on-a-chip technology: a novel approach to investigate cardiovascular diseases.
    Paloschi V; Sabater-Lleal M; Middelkamp H; Vivas A; Johansson S; van der Meer A; Tenje M; Maegdefessel L
    Cardiovasc Res; 2021 Dec; 117(14):2742-2754. PubMed ID: 33729461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlling Microenvironments with Organs-on-Chips for Osteoarthritis Modelling.
    Ong LJY; Fan X; Rujia Sun A; Mei L; Toh YC; Prasadam I
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors.
    Zhang YS; Aleman J; Shin SR; Kilic T; Kim D; Mousavi Shaegh SA; Massa S; Riahi R; Chae S; Hu N; Avci H; Zhang W; Silvestri A; Sanati Nezhad A; Manbohi A; De Ferrari F; Polini A; Calzone G; Shaikh N; Alerasool P; Budina E; Kang J; Bhise N; Ribas J; Pourmand A; Skardal A; Shupe T; Bishop CE; Dokmeci MR; Atala A; Khademhosseini A
    Proc Natl Acad Sci U S A; 2017 Mar; 114(12):E2293-E2302. PubMed ID: 28265064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation.
    Lin KC; Torga G; Sun Y; Pienta KJ; Sturm JC; Austin RH
    J Vis Exp; 2019 Sep; (151):. PubMed ID: 31609331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.
    Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ
    Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Organ-on-a-chip technology and microfluidic whole-body models for pharmacokinetic drug toxicity screening.
    Lee JB; Sung JH
    Biotechnol J; 2013 Nov; 8(11):1258-66. PubMed ID: 24038956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microvascularized tumor organoids-on-chips: advancing preclinical drug screening with pathophysiological relevance.
    Lim J; Ching H; Yoon JK; Jeon NL; Kim Y
    Nano Converg; 2021 Apr; 8(1):12. PubMed ID: 33846849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On-chip recapitulation of the tumor microenvironment: A decade of progress.
    Giannitelli SM; Peluzzi V; Raniolo S; Roscilli G; Trombetta M; Mozetic P; Rainer A
    Biomaterials; 2024 Apr; 306():122482. PubMed ID: 38301325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From 3D cell culture to organs-on-chips.
    Huh D; Hamilton GA; Ingber DE
    Trends Cell Biol; 2011 Dec; 21(12):745-54. PubMed ID: 22033488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiologically Based Pharmacokinetic and Pharmacodynamic Analysis Enabled by Microfluidically Linked Organs-on-Chips.
    Prantil-Baun R; Novak R; Das D; Somayaji MR; Przekwas A; Ingber DE
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():37-64. PubMed ID: 29309256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microfluidic organs-on-chips.
    Bhatia SN; Ingber DE
    Nat Biotechnol; 2014 Aug; 32(8):760-72. PubMed ID: 25093883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.